Ovarian Cancer: State of the Art and Future Directions in Translational Research by George CoukosOvarian Cancer: State of the Art and Future Directions in Translational Research by George Coukos

Ovarian Cancer: State of the Art and Future Directions in Translational Research

EditorGeorge Coukos

Paperback | November 19, 2010

Pricing and Purchase Info

$383.89 online 
$414.95 list price save 7%
Earn 1919 plum® points

In stock online

Ships free on orders over $25

Not available in stores


Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.
Title:Ovarian Cancer: State of the Art and Future Directions in Translational ResearchFormat:PaperbackDimensions:320 pages, 9.25 × 6.1 × 0 inPublished:November 19, 2010Publisher:Springer New YorkLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1441923969

ISBN - 13:9781441923967

Look for similar items by category:


Table of Contents

Ovarian Cancer Detection and Pathogenesis 1Potential &limitations in early diagnosis of Ovarian cancerN Urban2SMRP and HE4 as biomarker for Ovarian carcinoma I Hellstorm3Classification of Ovarian cancer: A genomic analysisMJ Birrer4Epigenetic markers of ovarian cancerPM O'Brien5Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortiumA Berchuck6microRNA in human cancer: One step forward in diagnosis and treatmentL Zhang7Ovarian carcinogenesis, an alternative hypothesesJMJ Piek8BRCA1 induced Ovarian oncogenesis.L Dubeau9Role of p53 and Rb in ovarian cancerA Nikitin10Ovulatory factor in ovarian carcinogenesis.W MurdochOvarian Cancer Therapeutics11Gynecologic Oncology group trials in Ovarian CancerR Ozols12Platinum Combinations for frontline chemotherapy of advanced ovarian carcinoma G Aravantinos13Intraperitoneal chemotherapy of Ovarian CancerM Morgan14Ovarian cancer- can we reverse drug resistance?S Kaye15Nanoparticulate Paclitaxel, Nanotax, in ovarian cancerPF Terranova16Individualized molecular Medicine: Targeting the p13K pathway. G Mills17Defective Apoptosis underlies chemoresistance in Ovarian CancerR Liu18Nanoparticle delivery of suicide DNA for epithelial Ovarian cancer therapy.JA Sawicki19Biological therapy with oncolytic Herpes virusF Benencia20Cancer immunotherapy:Perspectives & prospectsM Papamichail21Regulatory T cells: A New Frontier in Cancer ImmunotherapyT curiel22Inhibitory B7 family members in human ovarian carcinoma.WZou23Vascular leukocytes: a new target in ovarian cancer.G Coukos24Heparin-binding EGF-like growth factor as a new target molecule for cancer therapyE Mekada